Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and Safety of Olmertasan in elderly patients with mild to moderate hypertension

Next Previous
Trial Profile

Efficacy and Safety of Olmertasan in elderly patients with mild to moderate hypertension

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Ramipril
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms ESPORT

    • Most Recent Events

    • 08 Sep 2010 An open-label follow-on study will continue on from the 12-week randomisation portion of this trial, as reported in Journal of hypertension.
    • 08 Sep 2010 Full results were presentd in an article in the Journal of Hypertension.
    • 21 Jun 2010 Results presented at the 20th European Meeting on Hypertension.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top